PRISM II: An Open-Label Study to Assess the Safety, Tolerability, and Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Results from the Alzheimer's Disease/Dementia Cohort
Doody, Rachelle S., D'Amico, Stephen, Cutler, Andrew J., Shin, Paul, Ledon, Frederic, Yonan, Charles, Siffert, JoaoVolume:
23
Langue:
english
Journal:
The American Journal of Geriatric Psychiatry
DOI:
10.1016/j.jagp.2014.12.170
Date:
March, 2015
Fichier:
PDF, 253 KB
english, 2015
File converter
Plus de résultats de recherche
More benefits 
